Surrey Heartlands

Joint Formulary & PAD

Semaglutide - Weight management in adolescents

You are here : Home > Formulary Search > Semaglutide - Weight management in adolescents

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :

No records returned.

Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Only for the ASPH pilot clinics in young people aged 12 to 16 years.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Semaglutide
Indication :
Weight management in adolescents
Group Name :
Keywords :
obesity, weight loss, overweight
Brand Names Include :
Wegovy
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Semaglutide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Weight management in adolescents.

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Wegovy® should only be prescribed within Ashford & St Peters pilot site clinics for children and young people(12 to 16 years) from Surrey Heartlands with severe complications of excess weight. Wegovy®, is only a small component of the service, and will only be considered for a sub-section of the CYP in this pilot.

Referrals to the service need to be made by Paediatricians

Do NOT prescribe Wegovy ®, or semaglutide for the treatment of obesity in primary care.

Alternatively, for all children or teenagers aged 5-17 years with concerns about their weight, can be referred to the Be your Best service by their primary care team, or can self-refer for better health.